India  

Pfizer Says Updated COVID-19 Shot Effective Against Omicron

Video Credit: Wibbitz Top Stories - Duration: 01:30s - Published
Pfizer Says Updated COVID-19 Shot Effective Against Omicron

Pfizer Says Updated COVID-19 Shot Effective Against Omicron

Pfizer Says Updated COVID-19 Shot , Effective Against Omicron.

NBC News reports Pfizer announced on June 25 that its updated coronavirus vaccine better targets the omicron variant.

Experts say while current vaccines offer ample protection against new variants, .

Their effectiveness has waned in the age of omicron.

The Food and Drug Administration has considered ordering altered vaccines, .

Hoping a modified recipe could offer more protection when coronavirus surges again this fall and winter.

Pfizer says after studying over 1,200 adults who had received three vaccine doses.

Officials say each of their vaccines showed a substantial increase in omicron-resistant antibodies.

Based on these data, we believe we have two very strong omicron- adapted candidates.

, statement from Pfizer CEO Albert Bourla, via NBC News.

Pfizer's tweaked shot shows a 9 to 11-fold increase in omicron-fighting antibodies.

Almost 1.5 times higher than the company's initial dose


You Might Like


💡 newsR Knowledge: Other News Mentions

Pfizer Pfizer American multinational pharmaceutical and biotechnology corporation

Biden’s COVID-19 Symptoms Are Almost Gone, White House Doctor Says [Video]

Biden’s COVID-19 Symptoms Are Almost Gone, White House Doctor Says

Biden’s COVID-19 Symptoms Are Almost Gone, , White House Doctor Says. Last week, President Biden revealed he'd been diagnosed with COVID and was taking Paxlovid to treat his mild symptoms. . Last week, President Biden revealed he'd been diagnosed with COVID and was taking Paxlovid to treat his mild symptoms. . NPR reports that according to his physician, Dr. Kevin O'Connor, the president's symptoms "have now almost completely resolved.". NPR reports that according to his physician, Dr. Kevin O'Connor, the president's symptoms "have now almost completely resolved.". Dr. O'Connor says Biden currently has "residual nasal congestion and minimal hoarseness" following four days of taking Pfizer's antiviral pills. . Dr. O'Connor says Biden currently has "residual nasal congestion and minimal hoarseness" following four days of taking Pfizer's antiviral pills. . The president's pulse, blood pressure, temperature and oxygen levels are all normal. . NPR reports Biden is scheduled to remain in isolation through July 26. After that, if he receives a negative COVID test and feels well following his Paxlovid treatment. he could resume normal activities by July 27. The White House remains adamant that Biden's symptoms have been mild due to the fact that he is vaccinated and double boosted... ... in addition to starting Paxlovid as soon as he tested positive

Credit: Wibbitz Top Stories    Duration: 01:31Published
FDA Calls for Fall COVID Boosters To Target Omicron Subvariants [Video]

FDA Calls for Fall COVID Boosters To Target Omicron Subvariants

FDA Calls for Fall COVID Boosters , To Target Omicron Subvariants. NBC News reports that on June 30, the Food and Drug Administration asked vaccine makers to modify upcoming booster shots to target subvariants of Omicron. The Omicron subvariants the agency wishes to target are BA.4 and BA.5. Officials have called on vaccine makers Pfizer-BioNTech and Moderna to produce bivalent vaccines, . which are intended to target the original strain of COVID-19 as well as its subvariants. As we move into the fall and winter, it is critical that we have safe and effective vaccine boosters that can provide protection... , Dr. Peter Marks, FDA, via NBC News. ... against circulating and emerging variants to prevent the most severe consequences of COVID-19. , Dr. Peter Marks, FDA, via NBC News. As of the week ending June 25, Omicron subvariants BA.4 and BA.5 were responsible for 52% of all new cases of COVID-19. Per the Centers for Disease Control and Prevention, BA.1, the first variant of Omicron, caused 0% of new cases. Pfizer and Moderna have thus far altered vaccines to target the original strain of COVID-19 and BA.1. which increased the immune response to earlier iterations, though both have waned in their efficacy against BA.4 and BA.5

Credit: Wibbitz Top Stories    Duration: 01:30Published
Elmo Gets Vaccinated Against COVID [Video]

Elmo Gets Vaccinated Against COVID

Elmo Gets Vaccinated , Against COVID. Earlier this month, Moderna and Pfizer/BioNTech vaccines were given emergency use authorization for children as young as six months old. The CDC also signed off on the shots for kids under 5. On June 28, 'Sesame Street' issued a public service announcement to spread the word. Elmo's dad, Louie, addressed getting his son vaccinated. Elmo's dad, Louie, addressed getting his son vaccinated. Was it safe? Was it the right decision?’ I talked to our pediatrician so I could make the right choice. I learned that Elmo getting vaccinated is the best way to keep himself, our friends, neighbors and everyone else healthy and enjoying the things they love, Louie, Elmo's dad, via 'Sesame Street'. According to a Kaiser Family Foundation Vaccine Monitor survey conducted in April, 38% of parents wanted to "wait and see" before vaccinating their young kids. According to a Kaiser Family Foundation Vaccine Monitor survey conducted in April, 38% of parents wanted to "wait and see" before vaccinating their young kids. Jeanette Betancourt, senior vice president of U.S. social impact at Sesame Workshop, issued a statement about the PSA. We hope that Louie and Elmo will inspire parents and caregivers across the country to speak with their healthcare providers and seek out information to learn about how the COVID-19 vaccines can keep young children and their families healthy, Jeanette Betancourt, senior vice president of U.S. social impact at Sesame Workshop, via CNN. The CDC reports that as of June 22, 30% of kids between the ages of 5 and 11 and 60% between the ages of 12 and 17 were fully vaccinated. The CDC reports that as of June 22, 30% of kids between the ages of 5 and 11 and 60% between the ages of 12 and 17 were fully vaccinated

Credit: Wibbitz Top Stories    Duration: 01:31Published
FDA Panel Endorses COVID Vaccines for Children Under 5 [Video]

FDA Panel Endorses COVID Vaccines for Children Under 5

FDA Panel , Endorses COVID Vaccines, for Children Under 5. On June 15, an advisory panel to the United States Food and Drug Administration voted to recommend two COVID-19 vaccines for kids ages 5 and under. Yahoo reports that both Pfizer/BioNTech and Moderna were under review by the panel. . The unanimous FDA panel vote is the first step in what is predicted to be a quick authorization process. According to Yahoo, data from trials shows that both vaccines continue to protect against severe disease, hospitalization and death. According to Yahoo, data from trials shows that both vaccines continue to protect against severe disease, hospitalization and death. Yahoo reports that parents now have two options for how to vaccinate their children. Pfizer's vaccine for kids is delivered in three, three-microgram doses, while Moderna's vaccine is delivered in two shots of a 25-microgram dose. Our robust clinical study shows that three doses can provide protection for the circulating Omicron variant and offers promise for protection against potential future waves of COVID-19, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research and Development head, via Yahoo. Our robust clinical study shows that three doses can provide protection for the circulating Omicron variant and offers promise for protection against potential future waves of COVID-19, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research and Development head, via Yahoo. The committee’s support today is imperative to providing a critical tool for pediatricians, parents, and caregivers who eagerly await an option for children under five, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research and Development head, via Yahoo. Both companies are now awaiting approval from the FDA and the CDC which will hold an advisory committee meeting on the topic over the weekend.

Credit: Wibbitz Top Stories    Duration: 01:30Published

Albert Bourla Albert Bourla CEO of Pfizer


Food and Drug Administration Food and Drug Administration Agency of the US Department of Health and Human Services

FDA Favors Updated COVID Boosters for Fall, Shelves Summer Boosters [Video]

FDA Favors Updated COVID Boosters for Fall, Shelves Summer Boosters

FDA Favors , Updated COVID Boosters for Fall, , Shelves Summer Boosters . The Food and Drug Administration announced that its focus is now on updated boosters for those under 50. The shots are scheduled to be available to the public in September. Many health professionals feel it is the right decision and could help to bolster trust in federal health institutions. We can't give a booster now and then again in 1.5 months or two months – that will decrease trust, Dr. Monica Gandhi, UC San Francisco, via NPR News. Health professionals explained why two boosters in a short period of time could be "counter-productive.". If you get a booster now with the original formulation of the vaccine, this may in fact be counter-productive. , Dr. Celine Gounder, Kaiser Family Foundation, via NPR News. It may prevent the second booster dose given this fall from taking and from you developing an immune response to that booster, Dr. Celine Gounder, Kaiser Family Foundation, via NPR News. Others expressed skepticism at the effectiveness of the planned updated booster. People should not regard them as some sort of magic bullet that gives them super-strong protection, Dr. John Moore, Weill Cornell Medicine, via NPR News. These are not going to be magic bullet game-changers because they're not that much better than the already available vaccine boosters, Dr. John Moore, Weill Cornell Medicine, via NPR News. Other professionals feel the plan to wait may put people at an unnecessary risk. You're talking about you know literally hundreds of millions of people who are at a higher risk than they need to be for months, Dr. Robert Wachter, UC San Francisco, via NPR News. And that will mean potentially millions of preventable infections, certainly thousands of preventable hospitalizations, and probably hundreds of preventable deaths, Dr. Robert Wachter, UC San Francisco, via NPR News

Credit: Wibbitz Top Stories    Duration: 01:30Published
Drugmaker Asks FDA to Approve Over-the-Counter Birth Control Pill [Video]

Drugmaker Asks FDA to Approve Over-the-Counter Birth Control Pill

Drugmaker Asks FDA , to Approve Over-The-Counter , Birth Control Pill. On July 11, a French pharmaceutical company sought regulatory approval to sell an over-the-counter birth control pill in the United States. NBC reports that HRA Pharma's application comes amid legal and political battles regarding women's reproductive health. However, the company said the timing for its application was unrelated to the Supreme Court's recent decision to overturn Roe v. Wade. According to NBC, hormone based birth control has long been the most widely used form of birth control in the U.S. . Since the 1960s, birth control has required a prescription and a medical screening for conditions that raise the risk of blood clots. The French drugmaker argues that years of research suggest that women can safely screen themselves for those conditions and use the pill effectively. For a product that has been available for the last 50 years, that has been used safely by millions of women, we thought it was time to make it more available, Frederique Welgryn, HRA’s chief strategy officer, via 'The Guardian'. NBC reports that FDA approval could come as soon as next year. . Reproductive rights advocates have reportedly been pushing for the approval of more over-the-counter contraceptives following the Roe v. Wade decision . . Reproductive rights advocates have reportedly been pushing for the approval of more over-the-counter contraceptives following the Roe v. Wade decision . . Now, the FDA likely faces intense political scrutiny as it weighs a potentially precedent-setting decision

Credit: Wibbitz Top Stories    Duration: 01:31Published
FDA To Pull Juul E-Cigarettes off US Market [Video]

FDA To Pull Juul E-Cigarettes off US Market

FDA To Pull Juul E-Cigarettes , off US Market. Fox News and other outlets report that the Food and Drug Administration (FDA) is gearing up to order Juul Labs Inc. to remove its e-cigarettes from store shelves in America. Fox News and other outlets report that the Food and Drug Administration (FDA) is gearing up to order Juul Labs Inc. to remove its e-cigarettes from store shelves in America. The announcement is expected to come as data presented by Juul has been under review for nearly two years. . The announcement is expected to come as data presented by Juul has been under review for nearly two years. . Fox News reports that four years ago, the vaping company came under fire for its fruity flavors and marketing direction. Fox News reports that four years ago, the vaping company came under fire for its fruity flavors and marketing direction. Fox News reports that four years ago, the vaping company came under fire for its fruity flavors and marketing direction. Critics say underage vaping surged as a result. Juul has since cut back on its marketing, and in 2019, the company stopped selling fruity, sweet cartridge flavors. . Still, sales have dramatically declined for the e-cigarette manufacturer. . The sale of all fruity e-cigarette flavors has since been banned by the FDA. Juul's impending departure would pave the way for Reynolds American Inc. and NJOY Holidings Inc. to corner the tobacco-flavored segment of the e-cigarette market. Juul's impending departure would pave the way for Reynolds American Inc. and NJOY Holidings Inc. to corner the tobacco-flavored segment of the e-cigarette market. Juul's impending departure would pave the way for Reynolds American Inc. and NJOY Holidings Inc. to corner the tobacco-flavored segment of the e-cigarette market. Fox News reports Juul will be able to file an appeal through the FDA, take the matter to court or file a new application with revised products. . Fox News reports Juul will be able to file an appeal through the FDA, take the matter to court or file a new application with revised products.

Credit: Wibbitz Top Stories    Duration: 01:30Published